Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2011 Nov 18;6(11):10.1371/annotation/05c1b976-7eab-4154-808d-0526e604b8eb. doi: 10.1371/annotation/05c1b976-7eab-4154-808d-0526e604b8eb

Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

Patricia Spilman, Natalia Podlutskaya, Matthew J Hart, Jayanta Debnath, Olivia Gorostiza, Dale Bredesen, Arlan Richardson, Randy Strong, Veronica Galvan
PMCID: PMC3227689

The affiliation for the first author was incorrect. Patricia Spilman is not affiliated with #8 but with #1 Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America, and #2 The Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.

Footnotes

Competing Interests: No competing interests declared.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES